Content provided by Dr. Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
Metastatic BRCA-Negative, Triple-Negative Breast Cancer — An Interview with Prof Peter Schmid on Optimal Management
MP3•Episode home
Manage episode 507926909 series 1212572
Content provided by Dr. Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Prof Peter Schmid from Barts Cancer Institute in London reviews available efficacy and safety data guiding the optimal management of metastatic triple-negative breast cancer.
CME information and select publications here.
303 episodes
MP3•Episode home
Manage episode 507926909 series 1212572
Content provided by Dr. Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Prof Peter Schmid from Barts Cancer Institute in London reviews available efficacy and safety data guiding the optimal management of metastatic triple-negative breast cancer.
CME information and select publications here.
303 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.